vs
凯特制药（NAMS）与RIVERVIEW BANCORP INC（RVSB）财务数据对比。点击上方公司名可切换其他公司
凯特制药的季度营收约是RIVERVIEW BANCORP INC的1.4倍（$19.1M vs $14.0M），RIVERVIEW BANCORP INC净利率更高（9.8% vs -90.7%，领先100.5%），凯特制药同比增速更快（740.1% vs 10.4%），RIVERVIEW BANCORP INC自由现金流更多（$-736.0K vs $-37.8M）
凯特制药是一家美国生物技术企业，专注于研发癌症免疫治疗产品，核心方向为基因工程改造的自体嵌合抗原受体T细胞（CAR-T）疗法，这是一种基于嵌合抗原受体与T细胞的细胞治疗技术。公司成立于2009年，总部位于加利福尼亚州圣莫尼卡，2017年被吉利德科学收购。
Riverview Bancorp Inc.是一家总部位于美国的银行控股公司，主营个人与商业银行业务，服务覆盖太平洋西北地区，提供存款、消费贷款、住房抵押贷款、商业信贷及小企业金融等产品，服务零售客户与本地企业群体。
NAMS vs RVSB — 直观对比
营收规模更大
NAMS
是对方的1.4倍
$14.0M
营收增速更快
NAMS
高出729.7%
10.4%
净利率更高
RVSB
高出100.5%
-90.7%
自由现金流更多
RVSB
多$37.0M
$-37.8M
损益表 — Q2 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $19.1M | $14.0M |
| 净利润 | $-17.4M | $1.4M |
| 毛利率 | — | — |
| 营业利润率 | -186.1% | 12.4% |
| 净利率 | -90.7% | 9.8% |
| 营收同比 | 740.1% | 10.4% |
| 净利润同比 | 55.5% | 11.8% |
| 每股收益（稀释后） | $-0.15 | $0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NAMSRVSB
| Q4 25 | — | $14.0M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | $19.1M | $13.3M | ||
| Q1 25 | — | $12.9M | ||
| Q4 24 | $12.8M | $12.7M | ||
| Q3 24 | $29.1M | $12.8M | ||
| Q2 24 | — | $12.2M | ||
| Q1 24 | — | $9.0M |
净利润NAMSRVSB
| Q4 25 | — | $1.4M | ||
| Q3 25 | — | $1.1M | ||
| Q2 25 | $-17.4M | $1.2M | ||
| Q1 25 | — | $1.1M | ||
| Q4 24 | $-92.2M | $1.2M | ||
| Q3 24 | $-16.6M | $1.6M | ||
| Q2 24 | — | $966.0K | ||
| Q1 24 | — | $-3.0M |
营业利润率NAMSRVSB
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 10.2% | ||
| Q2 25 | -186.1% | 11.7% | ||
| Q1 25 | — | 11.3% | ||
| Q4 24 | -338.5% | 12.4% | ||
| Q3 24 | -85.9% | 15.5% | ||
| Q2 24 | — | 10.0% | ||
| Q1 24 | — | -47.5% |
净利率NAMSRVSB
| Q4 25 | — | 9.8% | ||
| Q3 25 | — | 8.1% | ||
| Q2 25 | -90.7% | 9.2% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | -721.7% | 9.7% | ||
| Q3 24 | -57.2% | 12.2% | ||
| Q2 24 | — | 7.9% | ||
| Q1 24 | — | -34.7% |
每股收益（稀释后）NAMSRVSB
| Q4 25 | — | $0.07 | ||
| Q3 25 | — | $0.05 | ||
| Q2 25 | $-0.15 | $0.06 | ||
| Q1 25 | — | $0.05 | ||
| Q4 24 | $-0.91 | $0.06 | ||
| Q3 24 | $-0.18 | $0.07 | ||
| Q2 24 | — | $0.05 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $739.2M | $28.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $778.5M | $164.2M |
| 总资产 | $815.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NAMSRVSB
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $32.8M | ||
| Q2 25 | $739.2M | $34.2M | ||
| Q1 25 | — | $29.4M | ||
| Q4 24 | $834.2M | $25.3M | ||
| Q3 24 | $422.7M | $31.0M | ||
| Q2 24 | — | $27.8M | ||
| Q1 24 | — | $23.6M |
股东权益NAMSRVSB
| Q4 25 | — | $164.2M | ||
| Q3 25 | — | $163.5M | ||
| Q2 25 | $778.5M | $162.0M | ||
| Q1 25 | — | $160.0M | ||
| Q4 24 | $757.5M | $158.3M | ||
| Q3 24 | $378.9M | $160.8M | ||
| Q2 24 | — | $155.9M | ||
| Q1 24 | — | $155.6M |
总资产NAMSRVSB
| Q4 25 | — | $1.5B | ||
| Q3 25 | — | $1.5B | ||
| Q2 25 | $815.1M | $1.5B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $864.6M | $1.5B | ||
| Q3 24 | $439.2M | $1.5B | ||
| Q2 24 | — | $1.5B | ||
| Q1 24 | — | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-37.7M | $-506.0K |
| 自由现金流经营现金流 - 资本支出 | $-37.8M | $-736.0K |
| 自由现金流率自由现金流/营收 | -197.2% | -5.2% |
| 资本支出强度资本支出/营收 | 0.5% | 1.6% |
| 现金转化率经营现金流/净利润 | — | -0.37× |
| 过去12个月自由现金流最近4个季度 | $-119.7M | $20.4M |
8季度趋势，按日历期对齐
经营现金流NAMSRVSB
| Q4 25 | — | $-506.0K | ||
| Q3 25 | — | $16.8M | ||
| Q2 25 | $-37.7M | $-697.0K | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | $-37.5M | $2.2M | ||
| Q3 24 | $-12.5M | $764.0K | ||
| Q2 24 | — | $5.4M | ||
| Q1 24 | — | $12.8M |
自由现金流NAMSRVSB
| Q4 25 | — | $-736.0K | ||
| Q3 25 | — | $16.4M | ||
| Q2 25 | $-37.8M | $-773.0K | ||
| Q1 25 | — | $5.6M | ||
| Q4 24 | $-37.5M | $1.9M | ||
| Q3 24 | $-12.6M | $-1.4M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | — | $7.1M |
自由现金流率NAMSRVSB
| Q4 25 | — | -5.2% | ||
| Q3 25 | — | 120.1% | ||
| Q2 25 | -197.2% | -5.8% | ||
| Q1 25 | — | 43.1% | ||
| Q4 24 | -293.5% | 15.0% | ||
| Q3 24 | -43.2% | -11.3% | ||
| Q2 24 | — | 43.7% | ||
| Q1 24 | — | 79.0% |
资本支出强度NAMSRVSB
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | 0.5% | 0.6% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | 0.0% | 2.4% | ||
| Q3 24 | 0.3% | 17.3% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 62.0% |
现金转化率NAMSRVSB
| Q4 25 | — | -0.37× | ||
| Q3 25 | — | 15.25× | ||
| Q2 25 | — | -0.57× | ||
| Q1 25 | — | 7.20× | ||
| Q4 24 | — | 1.79× | ||
| Q3 24 | — | 0.49× | ||
| Q2 24 | — | 5.63× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
